analyzátory močové iq200, ichem velocity
iris diagnostics 9172 eton avemue 91311 chatsworth, california spojené štáty americké -
iberogast
bayer, spol. s r.o., slovensko - lieČivÁ na funkČnÉ gastrointestinÁlne poruchy - 94 - fytopharmaca
epysqli
samsung bioepis nl b.v. - eculizumab - hemoglobinúria, paroxysmálna - imunosupresíva - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.
bekemv
amgen technology (ireland) uc - eculizumab - hemoglobinúria, paroxysmálna - imunosupresíva - bekemv is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). dôkazy z klinických výhodou je preukázaná u pacientov s haemolysis s klinický príznak(s) svedčí o vysokej aktivity ochorenia, bez ohľadu na transfúziu históriu (pozri časť 5.
urapidil kalceks 50 mg injekčný/infúzny roztok
as kalceks, lotyšsko - urapidil - 58 - hypotensiva
urapidil kalceks 25 mg injekčný/infúzny roztok
as kalceks, lotyšsko - urapidil - 58 - hypotensiva
iberogast neo
bayer, spol. s r.o., slovensko - lieČivÁ na funkČnÉ gastrointestinÁlne poruchy - 94 - fytopharmaca
tysabri
biogen netherlands b.v. - natalizumab - roztrúsená skleróza - selektívne imunosupresíva - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 a 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
ervebo
merck sharp & dohme b.v. - rekombinantnej vírus vezikulárnej stomatitídy (kmeň indiana) s odstránením obálky glykoproteín, v súlade s zair ebolavirus (kmeň kikwit 1995) povrch glykoproteín - hemorrhagic fever, ebola - vakcíny - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. použitie ervebo by mali byť v súlade s oficiálne odporúčania.
risperidon teva 50 mg prášok a vehikulum na injekčnú suspenziu s predĺženým uvoľňovaním
teva pharmaceuticals slovakia s.r.o., slovensko - risperidón - 68 - antipsychotica (neuroleptica)